The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease
Abstract
BACKGROUND: Pseudomonas aeruginosa infections are increasingly associated with acute exacerbations in chronic obstructive pulmonary disease (COPD). We aimed to determine whether an underlying chronic infection might be behind this process and to determine the epidemiological characteristics of the isolates involved, to implement useful protocols for preventing and treating these infections. METHODS: P. aeruginosa isolates obtained from respiratory samples of 13 patients with COPD and from blood samples of 10 patients in intensive care units were investigated. In 8 patients with COPD, isolates were obtained during sequential exacerbation episodes. Five patients presented a single infection episode. Production of virulence determinants and genetic relationships were analyzed in all isolates. RESULTS: Patients with COPD were usually infected with 1 P. aeruginosa clone that remained in the lung for years, without evidence of interpatient transmission. During chronic infection, each clone diversified, which led to the coexistence of isolates with different morphotypes and antibiotic susceptibility. Overall, P. aeruginosa evolved toward an increased mutation rate, increased antibiotic resistance, and reduced production of proteases. Isolates from samples of infected lungs tend to be less cytotoxic and motile and to produce more biofilm, compared with isolates from blood samples. CONCLUSION: These results provide the first evidence supporting the hypothesis that P. aeruginosa causes chronic infections in COPD, with patterns of infection and evolution that resemble those observed in cystic fibrosis. Experience gained from treating cystic fibrosis might be useful for implementing new procedures for the prevention, diagnosis, and treatment of infection due to P. aeruginosa in COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also highly problematic in lung infections, especially in people with the genetic disease cystic fibrosis7, chronic pulmonary disease8 and ventilator-associated pneumonia9.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Self-citationNew Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
Antibiotics as intermicrobial signaling agents instead of weapons
Linares, J. F., Gustafsson, I., Baquero, F., & Martinez, J. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608949103 · Cited by 658
Self-citationGoodman, A. L., Kulasekara, B., Rietsch, A., Boyd, D., Smith, R. S., & Lory, S. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.020 · Cited by 628
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Miravitlles, M., Espinosa, C., Fernández-Laso, E., Martos, J. A., Maldonado, J. A., & Gallego, M. (1999) · Chest · doi:10.1378/chest.116.1.40 · Cited by 445
Plants and animals share functionally common bacterial virulence factors
Rahme, L. G., Ausubel, F. M., Cao, H., Drenkard, E., Goumnerov, B. C., Lau, G. W., Mahajan-Miklos, S., Plotnikova, J., Tan, M.-W., Tsongalis, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8815 · Cited by 416
Overhage, J., Bains, M., Brazas, M. D., & Hancock, R. E. W. (2008) · Journal of Bacteriology · doi:10.1128/jb.01659-07 · Cited by 358
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
Kipnis, E., Sawa, T., & Wiener-Kronish, J. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.10.007 · Cited by 353
Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3382-3386.2005 · Cited by 309
Self-citationA major Pseudomonas aeruginosa clone common to patients and aquatic habitats
Römling, U., Wingender, J., Müller, H., & Tümmler, B. (1994) · Applied and Environmental Microbiology · doi:10.1128/aem.60.6.1734-1738.1994 · Cited by 287
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Murphy, T. F., Brauer, A. L., Eschberger, K., Lobbins, P., Grove, L., Cai, X., & Sethi, S. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1413oc · Cited by 280
Alonso, A., Rojo, F., & Martínez, J. L. (1999) · Environmental Microbiology · doi:10.1046/j.1462-2920.1999.00052.x · Cited by 222
Ratjen, F., Döring, G., & Nikolaizik, W. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06124-4 · Cited by 218
Jelsbak, L., Johansen, H. K., Frost, A.-L., Thøgersen, R., Thomsen, L. E., Ciofu, O., Yang, L., Haagensen, J. A. J., Høiby, N., & Molin, S. (2007) · Infection and Immunity · doi:10.1128/iai.01282-06 · Cited by 212
Fitness of in vitro selected Pseudomonas aeruginosanalB and nfxB multidrug resistant mutants
Sanchez, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf185 · Cited by 209
Foweraker, J. E. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki146 · Cited by 184
Linares, J. F., López, J. A., Camafeita, E., Albar, J. P., Rojo, F., & Martínez, J. L. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1384-1391.2005 · Cited by 184
Self-citationJain, M., Ramirez, D., SESHADRI, R. M., Cullina, J. F., Powers, C. A., Schulert, G. S., Bar‐Meir, M., Sullivan, C., McColley, S. A., & Hauser, A. R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5229-5237.2004 · Cited by 169
Cantón, R., Cobos, N., de Gracia, J., Baquero, F., Honorato, J., Gärtner, S., Alvarez, A., Salcedo, A., Oliver, A., & Garcia-Quetglas, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01217.x · Cited by 158
Self-citationCheer, S. M., Waugh, J., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363220-00015 · Cited by 142
Høiby, N. (2002) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00104-2 · Cited by 138
Struelens, M. J., Schwam, V., Deplano, A., et al. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.9.2320-2326.1993 · Cited by 126
Remschmidt, H., & Schmidt, M. H. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_47 · Cited by 109
Tingpej, P., Smith, L., Rose, B. R., Zhu, H., Conibear, T. C. R., Alnassafi, K., Manos, J., Elkins, M. R., Bye, P. T. P., Willcox, M. D. P., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02364-06 · Cited by 108
Morales, G., Wiehlmann, L., Gudowius, P., van Delden, C., Tümmler, B., Martínez, J. L., & Rojo, F. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.13.4228-4237.2004 · Cited by 92
Pseudomonal Infections in Patients with COPD
Lieberman, D. B., & Lieberman, D. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256673 · Cited by 80
Puhan, M. A., Vollenweider, D. J., Latshang, T. D., Steurer, J., & Steurer-Stey, C. A. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-30 · Cited by 80
Navas, A., Cobas, G., Talavera, M., Ayala, J. A., López, J. A., & Martínez, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704497104 · Cited by 34
The Role of Airway Secretions in COPD—Clinical Applications
Henke, M. O., Shah, S. A., & Rubin, B. K. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550500218148 · Cited by 20
Factors Associated With Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Tan, W. C. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-120039210 · Cited by 14
Cited by
Evolving concepts in biofilm infections
Hall-Stoodley, L., & Stoodley, P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01323.x · Cited by 1,136
Strategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Antimicrobial susceptibility testing in biofilm-growing bacteria
Macia, M. D., Rojo-Molinero, E., & Oliver, A. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12651 · Cited by 537
Self-citationA global view of antibiotic resistance
Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martínez-Solano, L., & Sánchez, M. B. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00142.x · Cited by 356
Self-citationVij, N., Chandramani-Shivalingappa, P., Van Westphal, C., Hole, R., & Bodas, M. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00110.2016 · Cited by 329
Metadata
- Authors
- Martínez‐Solano, L., Macia, M. D., Fajardo, A., Oliver, A., & Martinez, J. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-15
- Volume
- 47
- Issue
- 12
- Pages
- 1526-1533
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164003656
- Cited by
- 257
- References
- 34
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.